Analysed ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) News Sources
ACAD Stock Clocks Worst Day In 2 Years After Alzheimer’s Psychosis Drug Misses Main Goal — Citi Cuts Drug’s Success Odds To 20%
24-09-2026
stocktwits.com
ACADIA Pharmaceuticals (ACAD) Gets ‘Sell’ Rating on Weak Trial Results, Shares Fall 13%
25-09-2026
yahoo.com
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
25-09-2026
biopharmadive.com
Acadia chugs on with Alzheimer’s psychosis programme despite Phase II miss
25-09-2026
clinicaltrialsarena.com
ACAD Stock Tumbles Today: Analysts Weigh RADIANT Results, Cut Price Targets
25-09-2026
stocktwits.com
Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041
28-09-2026
yahoo.com
What is the current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The current price of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is $19.78.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is $0.2.
ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) since the previous trading day is 1.0215%.
What is the most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent average sentiment score for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)?
The most recent sentiment for ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ) is .
SEC-8K** Filing Available For ACADIA PHARMACEUTICALS INC (ACAD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.